Whole-Body Distribution and Clinical Association of Telangiectases in Systemic Sclerosis.

ABSTRACT:

Importance

In systemic sclerosis (SSc), to date, no study has precisely described the total number and fine distribution of telangiectases (TAs), their clinical association with the disease, and the biological mechanisms causing their development.

Objectives

To describe the whole-body distribution of TAs and assess the association between the whole-body TA number and the characteristics of patients with SSc.

Design, setting, and participants

A single-center, cross-sectional study was conducted between July 11, 2016, and March 15, 2017, at the National Referral Centre for Rare Systemic and Autoimmune Diseases in France. A population-based sample of 106 adults who fulfilled the 2013 American College of Rheumatology/European League Against Rheumatism criteria for SSc wer

SUBMITTER: Jouvray M 

PROVIDER: S-EPMC6128493 | biostudies-literature | 2018 Jul

REPOSITORIES: biostudies-literature